In collaboration with clinical medical centers and Nanjing Agricultural University, Newline Bio co-published breakthrough research in Frontiers in Microbiology on prophage mining in clinical MRSA strains and the discovery of novel endolysin Lys81, demonstrating potent lytic efficacy across multidrug-resistant staphylococcal biofilms.
A primary concern among livestock producers transitioning from antibiotics is whether chronic phage exposure mimics antibiotic resistance. Evolutionary biology demonstrates that bacterial phage-resistance mutations carry severe fitness costs (attenuated virulence, restored antibiotic sensitivity). Furthermore, Newline Bio’s multi-receptor cocktail design continuously circumvents resistance mechanisms.
With broiler margins opening up, managing seasonal respiratory and systemic colibacillosis is decisive. Newline Bio’s automated phage fine aerosol spray protocol in poultry houses directly reduces airborne and surface pathogenic E. coli loads by multiple log orders, slashing early-stage mortality and airsacculitis.
Severe enrofloxacin and florfenicol residue exceedances in commercial bullfrog farming have triggered massive market penalties. Newline Bio’s targeted aquatic phage cocktail clears Aeromonas hydrophila and Edwardsiella in water and intestinal tracts, achieving complete antibiotic substitution without withdrawal delays.
Immature gut immunity makes neonate chicks exceptionally susceptible to perinatal colibacillosis and omphalitis. Supplying specific lytic bacteriophages in early drinking water equips chicks with rapid biological barriers that outcompete pathogens during the critical 72-hour window.
Salmonella Pullorum evades conventional antibiotics through intracellular persistence in macrophages and systemic vertical transmission. Newline Bio’s virulent phage cocktail intercepts pathogens prior to mucosal translocation, disrupting colonization cascades and providing breeder flocks with effective negative-status maintenance.
Conventional aquatic antibiotic treatments often trigger severe immunosuppression in aquatic animals, creating vulnerability to secondary opportunistic infections. Research confirms that precision phage therapy eliminates pathogens while sparing gut microbiota, actively upregulating serum and mucosal IgM antibody titers to bolster systemic defense.
In pet clinics, the pursuit of rapid clinical responses has led to growing reliance on carbapenems like imipenem—the last line of human medical defense. This abuse accelerates carbapenem-resistant Enterobacteriaceae (CRE) emergence. Newline Bio highlights precision lytic bacteriophages as sustainable, residue-free alternatives that protect both animal welfare and public health.
Amid worldwide regulatory bans on growth-promoting antibiotics, livestock and aquaculture face intense superbug pressure. The World Organisation for Animal Health (WOAH), FAO, and WHO increasingly champion bacteriophages as prime targeted non-antibiotic alternatives that eliminate pathogenic bacteria without triggering collateral antimicrobial resistance.
Export aquaculture operators—from white shrimp to tilapia and eel—face increasingly stringent international testing standards with near-zero tolerance for drug residues. Newline Bio’s marine phage cocktails provide targeted Vibrio and Aeromonas clearance, ensuring safe export compliance and superior harvest survival.
Repeated national food inspection bulletins highlighting veterinary antibiotic residues in eggs, poultry, and aquaculture have shaken consumer trust. Green bio-solutions utilizing virulent bacteriophages provide agricultural enterprises with zero-withdrawal, residue-free biological barriers from breeding to slaughter.
Combining host-specific lytic phages with probiotic Bacillus subtilis creates powerful symbiotic synergy: while bacteriophages swiftly decimate enteric pathogen loads (Salmonella, E. coli, Clostridium), Bacillus subtilis rapidly colonizes mucosal niches, secretes digestive enzymes, and accelerates epithelial villus regeneration to optimize feed conversion.